Quintiles Transitional Holdings Inc. (NYSE:Q) – Equities researchers at Jefferies Group decreased their FY2017 earnings estimates for Quintiles Transitional Holdings in a research report issued to clients and investors on Monday. Jefferies Group analyst D. Windley now forecasts that the medical research company will post earnings of $4.55 per share for the year, down from their prior forecast of $4.56. Jefferies Group currently has a “Hold” rating and a $94.00 target price on the stock. Jefferies Group also issued estimates for Quintiles Transitional Holdings’ Q3 2018 earnings at $1.28 EPS, Q4 2018 earnings at $1.47 EPS and FY2019 earnings at $5.89 EPS.

Several other equities analysts have also issued reports on Q. Zacks Investment Research lowered shares of Quintiles Transitional Holdings from a “buy” rating to a “hold” rating in a report on Thursday. Robert W. Baird restated a “hold” rating and issued a $98.00 target price on shares of Quintiles Transitional Holdings in a report on Monday. Royal Bank Of Canada assumed coverage on shares of Quintiles Transitional Holdings in a report on Tuesday, September 19th. They issued an “outperform” rating and a $116.00 target price on the stock. KeyCorp restated a “buy” rating and issued a $100.00 target price on shares of Quintiles Transitional Holdings in a report on Sunday, September 24th. Finally, Argus boosted their target price on shares of Quintiles Transitional Holdings from $98.00 to $104.00 and gave the company a “buy” rating in a report on Monday, September 18th. Eleven equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. Quintiles Transitional Holdings presently has a consensus rating of “Buy” and an average target price of $93.61.

TRADEMARK VIOLATION WARNING: “FY2017 Earnings Estimate for Quintiles Transitional Holdings Inc. (Q) Issued By Jefferies Group” was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/10/13/fy2017-earnings-estimate-for-quintiles-transitional-holdings-inc-q-issued-by-jefferies-group.html.

Quintiles Transitional Holdings (NYSE:Q) last issued its quarterly earnings data on Thursday, August 3rd. The medical research company reported $1.09 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.05 by $0.04. The business had revenue of $1.97 billion for the quarter, compared to the consensus estimate of $1.96 billion. Quintiles Transitional Holdings had a return on equity of 14.23% and a net margin of 0.82%. The firm’s revenue was up 68.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.93 EPS.

In other Quintiles Transitional Holdings news, major shareholder Cpp Investment Board Private H sold 6,748,026 shares of the company’s stock in a transaction dated Tuesday, September 19th. The shares were sold at an average price of $94.87, for a total value of $640,185,226.62. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Ari Bousbib sold 46,080 shares of the company’s stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $94.91, for a total transaction of $4,373,452.80. Following the completion of the sale, the insider now directly owns 1,036,839 shares of the company’s stock, valued at $98,406,389.49. The disclosure for this sale can be found here. Insiders sold a total of 14,198,382 shares of company stock worth $1,361,834,375 in the last 90 days. 6.40% of the stock is currently owned by company insiders.

A number of hedge funds have recently modified their holdings of Q. Vanguard Group Inc. grew its position in shares of Quintiles Transitional Holdings by 2.2% during the 2nd quarter. Vanguard Group Inc. now owns 12,789,723 shares of the medical research company’s stock valued at $1,144,680,000 after acquiring an additional 280,893 shares during the period. BlackRock Inc. grew its position in shares of Quintiles Transitional Holdings by 4,217.1% during the 1st quarter. BlackRock Inc. now owns 7,098,723 shares of the medical research company’s stock valued at $571,660,000 after acquiring an additional 6,934,290 shares during the period. KBC Group NV grew its position in shares of Quintiles Transitional Holdings by 53.3% during the 2nd quarter. KBC Group NV now owns 18,959 shares of the medical research company’s stock valued at $1,697,000 after acquiring an additional 6,591 shares during the period. Key Square Capital Management LLC bought a new position in shares of Quintiles Transitional Holdings during the 2nd quarter valued at approximately $2,738,000. Finally, AXA grew its position in shares of Quintiles Transitional Holdings by 85.4% during the 2nd quarter. AXA now owns 251,830 shares of the medical research company’s stock valued at $22,539,000 after acquiring an additional 115,993 shares during the period. 93.21% of the stock is owned by institutional investors and hedge funds.

Quintiles Transitional Holdings Company Profile

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Earnings History and Estimates for Quintiles Transitional Holdings (NYSE:Q)

Receive News & Stock Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related stocks with our FREE daily email newsletter.